logo

TRIB

Trinity Biotech·NASDAQ
--
--(--)
--
--(--)

TRIB fundamentals

Trinity Biotech (TRIB) released its earnings on May 15, 2025: revenue was 15.86M (YoY +18.09%), missed estimates; EPS was -1.2355 (YoY -72.12%), missed estimates.
Revenue / YoY
15.86M
+18.09%
EPS / YoY
-1.2355
-72.12%
Report date
May 15, 2025
Earnings Call
9:30 AM on May 23, 2025
Meeting link.
EPS
Q3,undefined
Q4,undefined
Q1,undefined
Q2,undefined
Q3,undefined
Q4,undefined
Q1,undefined
Q2,undefined
Q3,undefined
Q4,undefined
Q1,2020
Q2,2020
Q3,2020
Q4,2020
Q1,2021
Q2,2021
Q3,2021
Q4,2021
Q1,2022
Q2,2022
Q3,2022
Q4,2022
Q1,2023
Q2,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Actual
0.265-0.181.751.7950.5051.060.24430.3182-0.3908-1.4292-1.1735-1.325-0.8262-2.3961-0.7178-0.374-0.7139-0.4582-1.2355
Forecast
0.1500.50.70.30.350.40.35-0.2-0.15-0.2-0.3-0.3-0.45-0.7-0.6-0.67-0.54-0.3
Surprise
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
+76.67%
0.00%
+250.00%
+156.43%
+68.33%
+202.86%
-38.92%
-9.09%
-95.40%
-852.80%
-486.75%
-341.67%
-175.40%
-432.47%
-2.54%
+37.67%
-6.55%
+15.15%
-311.83%
Revenue
Q3,undefined
Q4,undefined
Q1,undefined
Q2,undefined
Q3,undefined
Q4,undefined
Q1,undefined
Q2,undefined
Q3,undefined
Q4,undefined
Q1,2020
Q2,2020
Q3,2020
Q4,2020
Q1,2021
Q2,2021
Q3,2021
Q4,2021
Q1,2022
Q2,2022
Q3,2022
Q4,2022
Q1,2023
Q2,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Actual
--------------------21.18M16.02M32.01M32.80M25.59M25.84M22.00M19.52M18.78M18.46M19.50M18.04M14.83M13.90M13.43M14.70M15.84M15.15M15.86M
Forecast
--------------------19.00M13.00M28.00M28.00M24.00M24.00M24.25M24.00M20.00M18.75M19.50M18.00M18.50M13.50M15.00M16.00M15.00M16.50M16.50M
Surprise
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
+11.46%
+23.26%
+14.34%
+17.14%
+6.64%
+7.68%
-9.26%
-18.65%
-6.12%
-1.53%
+0.01%
+0.20%
-19.84%
+2.95%
-10.48%
-8.10%
+5.62%
-8.17%
-3.90%

Earnings Call